肺癌
中医药
医学
肺癌的治疗
放射治疗
癌症医学
免疫疗法
重症监护医学
化疗
精密医学
临床实习
肿瘤科
癌症
医学物理学
替代医学
内科学
肺
家庭医学
传统医学
病理
作者
Zhang Li,Feiyue Zhang,Gaofeng Li
标识
DOI:10.1016/j.biopha.2021.111381
摘要
With the continuous breakthroughs in molecular biology and biochemistry, we have constantly made great progress in the treatment of lung cancer. There is no doubt that standard treatment (such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy) has greatly improved the prognosis of lung cancer populations. In particular, the immunotherapy has brought more and more good news to countless lung cancer patients. In contrast to these standard treatments, traditional Chinese medicine (TCM) rarely has a profound and comprehensive overview in the field of lung cancer. This article will summarize the latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice, which would carry forward the sophisticated TCM and promote the development of modern medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI